Press Room
Obesity Ups The Ante
08/07/2014
High body mass index (BMI) is associated with an elevated risk of various cancers in men and women, according to a new report.
Active Surveillance of the Small Renal Mass
08/04/2014
Active surveillance in kidney cancer involves closely observing the tumor with periodic imaging studies rather than immediately proceeding to an invasive treatment.
First molecular test kit for kidney cancer developed by researchers
08/02/2014
A team of researchers and doctors in Singapore has developed the first molecular test kit that can predict treatment and survival outcomes in kidney cancer patients.
Brazilian researchers identify RNA that regulates cell death
07/31/2014
Scientists were able to effect a 10-fold reduction in the volume of subcutaneous malignant tumors by administering local injections of a plasmid containing a RNA that modulates the action of an important gene in the process of programmed cell death.
A New Target for Fighting Clear Cell RCC?
07/26/2014
Scientists have discovered a new molecular target for therapy to fight clear cell renal cell carcinoma (RCC)...
Sunitinib or Everolimus First-Line for Kidney Cancer?
07/25/2014
The study, known as RECORD-3, was published online July 21 in the Journal of Clinical Oncology.
The ObamaCare-IRS Nexus
07/25/2014
The supposedly independent agency harassed the administration's political opponents and saved its health-care law.
Enzyme lost in 100 percent of kidney tumors analyzed
07/24/2014
The new study, published online this week in Nature, was led by Celeste Simon, PhD, a professor of Cell and Developmental Biology and the scientific director for the Abramson Family Cancer Research Institute at Penn.
Cytoreductive nephrectomy can benefit patients with mRCC
07/24/2014
Patients treated with targeted therapy for metastatic renal cell carcinoma (mRCC) may derive significant survival benefit from cytoreductive nephrectomy (CN), particularly if their initial prognosis is good, study findings indicate.
News Feed| Powered by NeonCRM |